Suraksha Clinic and Diagnostic IPO Details 2024
Suraksha Clinic and Diagnostic IPO Details 2024
IPO Status: Upcoming [29th Nov 2024 to 3rd Dec 2024]
Rated 3/5 by Team InvestorGain
IPO GMP Today
IPO Live Subscription
GMP Performance
IPO Dashboard
SME Dashboard
IPO Event Calendar
Right Issue Dashboard
NCD Dashboard
Sovereign Gold Bond (SGB)
Suraksha Clinic and Diagnostic IPO Detail
Recommendations
Subscription
Allotment Status
FAQ
GMP

Suraksha Clinic and Diagnostic IPO, a Mainline IPO of ₹846.25 Cr opens for subscription from 29-11-2024 to 03-12-2024. The IPO consists of ₹846.25 Cr offer for sale.
The face value is Rs 2 and the price band is fixed at 420.00-441.00 per share. You can apply to the Suraksha Clinic and Diagnostic Mainline IPO for a minimum lot of 34 shares amounting of Rs 14994.
The tentative listing date on the exchange (BSE, NSE) is 06-12-2024.
Stay tuned with us to get more details about Suraksha Clinic and Diagnostic Mainline IPO including business overview, financial performance, live subscription status, allotment details, daily grey market premium (GMP), listing date, and listing price.
Suraksha Clinic and Diagnostic IPO Details
IPO Issue Opening Date:29th Nov 2024IPO Issue Closing Date:3rd Dec 2024IPO Issue Price:₹420.00-441.00 Per ShareDRHP:Download DRHPRHP:Download RHPIPO Listing At:BSE, NSERetail Quota:Not less than 35% of the Net OfferIPO Issue Type:Book Build IssueIPO Issue Size:₹846.25 CrOffer for Sale:₹846.25 CrFace Value:₹2 Per Equity ShareIPO Discount:TBDPromoter Holding Pre IPO:61.07%Promoter Holding Post IPO:
Suraksha Clinic and Diagnostic IPO Important Dates
Get important updates regarding Suraksha Clinic and Diagnostic IPO tentative timeline covering IPO opening, closing, allotment, and listing dates. Dates are updated as they are announced.
Suraksha Clinic and Diagnostic IPO datesIPO ActivityDateBasis of Allotment Date*4th Dec 2024Refunds Initiation*5th Dec 2024Credit of Shares to Demat*5th Dec 2024IPO Listing Date*6th Dec 2024
- Tentative Dates
Suraksha Clinic and Diagnostic IPO Lots
IPO ActivityDateIssue Price₹420.00-441.00Market Lot:34 Shares1 Lot Amount:₹14994Min Small HNI Lots(2-10 Lakh):476 shares (14 lots) - ₹209916Min Big HNI Lots(10+ Lakh):2278 shares (67 lots) - ₹1004598
Suraksha Clinic and Diagnostic IPO GMP**
GMP DateIPO PriceGMPSub2 Sauda RateExpected Listing GainLast Updated27-11-2024441.000--₹441 (0%)27-Nov-2024 6:03IPO Live GMP
Zerodha Trade@20
Want to start your investment journey, join India’s Pioneer Discount Broker – ZERODHA – Free Delivery Trade, Maximum Rs 20 for F&O and Intraday, Free Direct Mutual Fund investment.Open Zerodha Account
**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.
About Company - Suraksha Clinic and Diagnostic
Suraksha Diagnostics is the largest integrated diagnostics chain headquartered in East India. The company offers one-stop integrated solutions for pathology and radiology testing, and medical consultation services through its operational network. As of Marc 31, 2024, it has 48 diagnostic centres, and 146 sample collection centres across West Bengal, Assam, Bihar, and Meghalaya.
Three of its laboratories has been certified with National Accreditation Board for Testing and Calibration Laboratories (NABL) certification, and two of its advanced diagnostic centres holding National Accreditation Board for Hospitals & Healthcare Providers (NABH) accreditation.
It offers comprehensive test with over 2300 tests cover a range of specialities. As of March 31, 2024, it has 788 routine pathology tests to 647 specialized pathology tests, 748 basic/intermediate radiology tests including X-rays, USG, CT scan, MRI, etc.
It derives majority of revenues from the B2C segment, which contributes 94% of total revenue from operations for the Fiscal 2024.
According to the CRISIL report, the diagnostic service market in India is expected to grow at 10%-12% CAGR and projected to reach from ₹870 billion in Fiscal 2024 to ₹1,375 billion by Fiscal 2028. The data reflects strong growth opportunity.
Информация по комментариям в разработке